EnWave Signs Collaboration Agreement with Second Pharmaceutical Company

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
today announced that it has signed a Collaboration Agreement (the "Agreement")
with a second pharmaceutical company (the "Collaborator"), to test Radiant
Energy Vacuum ("REV") technology as a potential method for the drying of
biologic material used for the production of protein-based therapeutics via the
Collaborator's proprietary process.


Initial positive lab results involving the Company's REV technology has
compelled the Collaborator to engage in a more thorough testing program, with
the goal of refining their processes and seeking FDA approval for the entire
procedure. 


"Our Collaborator is on the verge of potentially making a major breakthrough in
the global pharmaceutical industry," said Dr. Tim Durance, Co-CEO, EnWave
Corporation. "If REV can successfully contribute to their proprietary process,
EnWave will be positioned well to benefit from their potential success. This
collaboration will also provide the opportunity to get the REV method FDA
exposure and possible approval."


EnWave's dehydration technology portfolio for pharmaceuticals and biomaterials
includes freezeREV(TM), powderREV(TM) and bioREV(TM); each employing a
combination of microwave energy with a low pressure environment to achieve
rapid, highly controlled dehydration of live or active biological materials
stored in sterile vials or in bulk powder, with the goal of significantly
reducing the process time and cost of dehydration in comparison to
lyophilisation. 


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV)
dehydration technology. The company recently licensed REV technology to Milne
Fruit Products Inc, its first major U.S. customer, to support a launch of
healthy berry snacks and powders across most major markets in North America.
More recently, EnWave licensed REV technology to one of its Tier 1 multinational
partners from the list below. In addition, EnWave has entered a wide range of
research and collaboration agreements with an expanding list of multinational
partners, including Nestle, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray
Cranberries, Hormel, Bonduelle, Cherry Central, Sun-Maid Growers and Merck.
EnWave is introducing REV as a new dehydration standard in the food and
biological material sectors: potentially faster and cheaper than freeze drying,
with better end product quality than air drying or spray drying.


EnWave currently has six REV platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry fruits, vegetables, meat, herbs
and seafood quickly and at low-cost, while maintaining high levels of nutrition,
taste, texture and colour. The Company is also developing powderREV(TM) for bulk
dehydration of food cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of pastes,
gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods
to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies.
More information about EnWave is available at www.enwave.net.


EnWave Corporation 

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures and
financial results are forward-looking statements. These statements are not a
guarantee of future performance and involve a number of risks, uncertainties and
assumptions. There is no guarantee that the Company's REV technology can or will
improve processes in the target industry; even if the Company's REV technology
can be used as described in this document, there is no guarantee that such use
will result in orders for the Company's REV technology. All figures comparing
REV technologies to freeze drying or other dehydration technologies are provided
as examples of data obtained through the Company's own scientific and testing
programs; each product must be tested individually to determine the benefits of
using REV.
(TSXV:REV)
過去株価チャート
から 8 2024 まで 9 2024